Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 22, 2026.

A Research Strategy to Discover the Environmental Causes of Autism and Neurodevelopmental Disabilities

Philip J. Landrigan, Luca Lambertini, Linda S. Birnbaum

Environmental Health Perspectives · 2012 · Review · Public domain

doi:10.1289/ehp.1104285

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Autism, attention deficit/hyperactivity disorder (ADHD), mental retardation, dyslexia, and other biologically based disorders of brain development affect between 400,000 and 600,000 of the 4 million children born in the United States each year. The Centers for Disease Control and Prevention (CDC) has reported that autism spectrum disorder (ASD) now affects 1.13% (1 of 88) of American children and ADHD affects 14%. Treatment of these disorders is difficult; the disabilities they cause can last lifelong, and they are devastating to families. In addition, these disorders place enormous economic burdens on society.

Although discovery research to identify the potentially preventable causes of neuro-develop-mental disorders (NDDs) has increased in recent years, more research is urgently needed. This research encompasses both genetic and environ-mental studies.

Genetic research has received particular investment and attention (Autism Genome Project Consortium et al. 2007;;;; ) and has demonstrated that ASD and certain other NDDs have a strong hereditary component. Linkage studies have identified candidate autism susceptibility genes at multiple loci, most consistently on chromosomes 7q, 15q, and 16p (Autism Genome Project Consortium et al. 2007; ). Exome sequencing in sporadic cases of autism has detected new mutations, and copy number variant studies have identified several hundred copy number variants putatively linked to autism. The candidate genes most strongly implicated in NDD causation encode for proteins involved in synaptic architecture, neuro-transmitter synthesis (e.g., ©-amino-butyric acid serotonin), oxytocin receptors, and cation trafficking. No single anomaly predominates. Instead, autism appears to be a family of diseases with common pheno-types linked to a series of genetic anomalies, each of which is responsible for no more than 2–3% of cases. The total fraction of ASD attributable to genetic inheri-tance may be about 30–40%.

Exploration of the environmental causes of autism and other NDDs has been catalyzed by growing recognition of the exquisite sensitivity of the developing human brain to toxic chemicals. This susceptibility is greatest during unique “windows of vulnerability” that open only in embryonic and fetal life and have no later counter-part. “Proof of the principle” that early exposures can cause autism comes from studies linking ASD to medications taken in the first trimester of pregnancy—thalidomide, misoprostol, and valproic acid—and to first-trimester rubella infection.

This “proof-of-principle” evidence for environmental causation is supported further by findings from prospective birth cohort epidemio-logical studies, many of them supported by the National Institute of Environmental Health Sciences (NIEHS). These studies enroll women during pregnancy, measure prenatal exposures in real time as they occur, and then follow children longitudinally with periodic direct examinations to assess growth, development, and the presence of disease. Prospective studies are powerful engines for the discovery of etiologic associations between prenatal exposures and NDDs. They have linked autistic behaviors with prenatal exposures to the organophosphate insecticide chlorpyrifos and also with prenatal exposures to phthalates. Additional prospective studies have linked loss of cognition (IQ), dyslexia, and ADHD to lead, methyl-mercury, organophosphate insecticides, organo-chlorine insecticides, polychlorinated biphenyls, arsenic, manganese, polycyclic aromatic hydrocarbons, bisphenol A, brominated flame retardants, and perfluorinated compounds.

Toxic chemicals likely cause injury to the developing human brain either through direct toxicity or inter-actions with the genome. An expert committee convened by the U.S. National Academy of Sciences (NAS) estimated that 3% of neuro-behavioral disorders are caused directly by toxic environ-mental exposures and that another 25% are caused by inter-actions between environmental factors, defined broadly, and inherited susceptibilities. Epigenetic modification of gene expression by toxic chemicals that results in DNA methyla-tion, histone modification, or changes in activity levels of non-protein-coding RNA (ncRNAs) may be a mechanism of such gene–environment interaction. Epigenetic “marks” have been shown to be able to influence gene expression and alter high-order DNA structure.

A major unanswered question is whether there are still undiscovered environ-mental causes of autism or other NDDs among the thousands of chemicals currently in wide use in the United States. In the past 50 years, > 80,000 new synthetic chemicals have been developed. The U.S. Environmental Protection Agency has identified 3,000 “high production volume” (HPV) chemicals that are in widest use and thus pose greatest potential for human exposure. These HPV chemicals are used today in millions of consumer products. Children and pregnant women are exposed extensively to them, and CDC surveys detect quantifiable levels of nearly 200 HPV chemicals in the bodies of virtually all Americans, including pregnant women.

The significance of early chemical exposures for children’s health is not yet fully understood. A great concern is that a large number of the chemicals in widest use have not undergone even minimal assessment of potential toxicity, and only about 20% have been screened for potential toxicity during early development. Unless studies specifically examine develop-mental consequences of early exposures to untested chemicals, sub-clinical dysfunction caused by these exposures can go unrecognized for years. One example is the “silent epidemic” of childhood lead poisoning: From the 1940s to the 1980s, millions of American children were exposed to excessive levels of lead from paint and gasoline, resulting in reduced average intelligence by 2–5 IQ points. The late David Rall, former director of NIEHS, once observed that “If thalidomide had caused a 10-point loss of IQ instead of birth defects of the limbs, it would likely still be on the market”.

To begin formulation of a systematic strategy for discovery of potentially preventable environmental causes of autism and other NDDs, the Mount Sinai Children’s Environmental Health Center, with the support of the NIEHS and Autism Speaks, convened a workshop on “Exploring the Environmental Causes of Autism and Learning Disabilities.” This workshop produced a series of papers by leading researchers, some of which are published in this issue of Environmental Health Perspectives. It also generated a list of 10 chemi-cals and mixtures widely distributed in the environment that are already suspected of causing develop-mental neuro-toxicity:

Lead

Methylmercury

Polychlorinated biphenyls

Organophosphate pesticides

Organochlorine pesticides

Endocrine disruptors

Automotive exhaust

Polycyclic aromatic hydrocarbons

Brominated flame retardants

Perfluorinated compounds.

This list is not exhaustive and will almost certainly expand in the years ahead as new science emerges. It is intended to focus research in environmental causation of NDDs on a short list of chemicals where concentrated study has high potential to generate actionable findings in the near future. Its ultimate purpose is to catalyze new evidence-based programs for prevention of disease in America’s children.

References 36

  1. 1.

    Anway MD, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology. 2006;147(6):S43-S49.

    Not in our library10.1210/en.2005-1058

  2. 2.

    Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci. 2005;23:189-199.

    Not in our library10.1016/j.ijdevneu.2004.11.001

  3. 3.

    Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al2007 Mapping autism risk loci using genetic linkage and chromosomal rearrangements.Nat Genet39319328

    Not in our library10.1038/ng1985

  4. 4.

    Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, Dietrich KN, et al. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics. 2011;128(5):873-882.

    Not in our library10.1542/peds.2011-1335

  5. 5.

    Buxbaum JD, Hof PR. The emerging neuroscience of autism spectrum disorders. Brain Res. 2011;1380:1-2.

    Not in our library10.1016/j.brainres.2011.02.030

  6. 6.

    CDC (Centers for Disease Control and Prevention)2005 Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder–United States, 2003.MMWR Morb Mortal Wkly Rep54842847

    Not in our library

  7. 7.

    CDC (Centers for Disease Control and Prevention)2012 Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2008.MMWR Surveill Summ613119

    Not in our library

  8. 8.

    Daniels JL. Autism and the environment. Environ Health Perspect. 2006;114:A396.

    Not in our library10.1289/ehp.114-a396

  9. 9.
  10. 10.

    Eskenazi B, Rosas LG, Marks AR, Bradman A, Harley K, Holland N, et al. Pesticide toxicity and the developing brain. Basic Clin Pharmacol Toxicol. 2008;102(2):228-236.

    Not in our library10.1111/j.1742-7843.2007.00171.x

  11. 11.

    Fernandez TV, Sanders SJ, Yurkiewicz IR, Ercan-Sencicek AG, Kim YS, Fishman DO, et al. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry. 2012;71(5):392-402.

    Not in our library10.1016/j.biopsych.2011.09.034

  12. 12.

    Goldman LR. Chemicals and children’s environment: what we don’t know about risks. Environ Health Perspect. 1998;106(suppl 3):875-880.

    Not in our library10.1289/ehp.98106875

  13. 13.

    Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry. 2010;49(8):794-809.

    Not in our library10.1016/j.jaac.2010.05.005

  14. 14.

    Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals: a silent pandemic. Lancet. 2006;368(9553):2167-2178.

    Not in our library10.1016/s0140-6736(06)69665-7

  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.

    Landrigan PJ, Goldman LR. Children’s vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff. 2011;30(5):842-850.

    Not in our library10.1377/hlthaff.2011.0151

  20. 20.

    London L, Beseler C, Bouchard MF, Bellinger DC, Colosio C, Grandjean P, et al. Neurobehavioral and neurodevelopmental effects of pesticide exposures. Neurotoxicology. 2012.

    Not in our library10.1016/j.neuro.2012.01.004

  21. 21.

    Miodovnik A. Environmental neurotoxicants and developing brain. Mt Sinai J Med. 2011;78(1):58-77.

    Not in our library10.1002/msj.20237

  22. 22.

    Miodovnik A, Engel SM, Zhu C, Ye X, Soorya LV, Silva MJ, et al. Endocrine disruptors and childhood social impairment. Neurotoxicology. 2011;32(2):261-267.

    Not in our library10.1016/j.neuro.2010.12.009

  23. 23.

    Scientific Frontiers in Developmental Toxicology and Risk Assessment. 2000.

    Not in our library

  24. 24.

    Oken E, Radesky JS, Wright RO, Bellinger DC, Amarasiriwardena CJ, Kleinman KP, et al. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol. 2008;167(10):1171-1181.

    Not in our library10.1093/aje/kwn034

  25. 25.

    O’Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585-589.

    Not in our library10.1038/ng.835

  26. 26.

    Pastor PN, Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006. Vital Health Stat 10. 2008;(237):1-14.

    Not in our library

  27. 27.

    Perera FP Li Z Whyatt R Hoepner L Wang S Camann D 2009 Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years.Pediatrics1242e195e202; doi:[Online 20 July 2009)

    Not in our library10.1542/peds.2008-3506

  28. 28.

    Sakurai T, Cai G, Grice DE, Buxbaum JD. Genomic architecture of autism spectrum disorders. In: Textbook of Autism Spectrum Disorders (Hollander E, Kolevzon A, Coyle JT. eds). 2011;281-298.

    Not in our library

  29. 29.

    Stein CR, Savitz DA. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age. Environ Health Perspect. 2011;119:1466-1471.

    Not in our library10.1289/ehp.1003538

  30. 30.

    Trasande L, Liu Y. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Aff. 2011;30(5):863-870.

    Not in our library10.1377/hlthaff.2010.1239

  31. 31.
  32. 32.
  33. 33.

    Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20:63-68.

    Not in our library10.1016/j.nut.2003.09.011

  34. 34.

    Weiss B. Food additives and environmental chemicals as sources of childhood behavior disorders. J Am Acad Child Psychiatry. 1982;21:144-152.

    Not in our library10.1016/s0002-7138(09)60913-4

  35. 35.

    Winneke G. Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls. J Neurol Sci. 2011;308(1-2):9-15.

    Not in our library10.1016/j.jns.2011.05.020

  36. 36.

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.